European Psychiatry - Volume 33

24th European Congress of Psychiatry / European Psychiatry 33S (2016) S72–S115

S115

intervention the 16 young people participating in the program

experienced a mean weight gain of 1.8 kilograms, and a mean

increase inwaist circumference of 0.1 centimeters. The participants

were followed up for two years after initial referral.

Methods

During the two-year follow-up, participants had con-

tinuing access to an in house gym and weekly cooking groups, but

without the same intensity of follow-up. Two year follow-up data

were obtained from 11 participants form the original cohort.

Results

Mean weight gain at two-year follow-up was 0.90 (SD

8.7) kilograms, and this difference was not statistically significant

[

(10) = 0.3, NS]. Waist circumference decreased by 0.7 (SD 7.7)

centimeters, which was not t statistically significant [

(10) = 0.3,

NS]. Nine of the participants (82%) did not experience clinically

significant weight gain two years after initiation of antipsychotic

medication.

Conclusion

This two-year follow-up data demonstrated that it is

feasible to prevent weight gain in youth with first-episode psy-

chosis over the first two years of treatment.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.108

Others

FC105

Differences between countries in

adult acute psychiatric

hospitalization: Clinical features and

drug prescription in Spain and the

United States of America

L. Gonzalez-Blanco

∗

, S. B

estene-Medina , E. Torio-Ojea ,

I. Abad-Acebedo , J. Rodriguez-Revuelta , G. Paniagua-Calzon

Servicio de Salud del Principado de Asturias, Psiquiatría, Oviedo,

Spain

∗

Corresponding author.

Introduction

Diverse prescription patterns and differences in

length of psychiatry inpatient stay among European and American

countries have been reported

[1,2] .

Objectives

To describe and compare clinical features and drug

prescriptions in two Acute Psychiatric Units from Spain and USA.

Methods

Cross-sectional and comparative study. Sample: 73

inpatients from Reno (USA-Inpatients) and 65 from Oviedo (Spain-

Inpatients) admitted to public Adult Acute Psychiatric Unit over a

two-month period. Sociodemographic/clinical data and drug pre-

scription were collected.

Results

Sociodemographic/clinical comparison

( Table 1 )

and

drug prescription differences

( Table 2 ) a

re shown.

No significant differences in antipsychotics’ prescription except for

the most frequently used [risperidone in Spain (36%)/ziprasidone

in US (19.6%), Chi

= 39.7**].

Conclusions

(A) Psychiatric inpatients in US are younger, have

longer hospitalization, show more comorbid substance use disor-

der and differ from Spanish inpatients in frequency of diagnostic

categories (schizophrenic disorders represent a larger proportion).

(B) Inpatients in Spain usually receive polytherapy, and are more

frequently treated with antidepressants and anxiolytics, especially

benzodiazepines. In contrast, USA-Inpatients take lithium more

often

[1,2] .

Table 1

Table 2

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

References

[1] Bitter, Chou, Ungvari, et al. Prescribing for inpatients with

schizophrenia: an international multi-center comparative

study. Pharmacopsychiatry 2003;36(4):143–9.

[2] Auffarth, Busse, Dietrich, et al. Length of psychiatry inpatient

stay: comparison ofmental health care outlining a casemix from

a hospital in Germany and the United States of America. German

J Psychiatry 2008;11:40–4.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.109